Cord Blood Stem Cells for Hematopoietic Transplantation

Anfisa Stanevsky, Avichai Shimoni, Ronit Yerushalmi, Arnon Nagler*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Cord blood (CB) is an important alternative source of hematopoietic stem cells (HSCs) for transplantation today. The principal drawbacks of cord blood transplantation are the limited number of hematopoietic stem cells and a long time to engraftment. Several promising approaches for engraftment enhancement are under intensive investigation. Such are transplantation with two cord blood units, co transplantation of cord blood and haploidentical HSCs and different methods for expansion of cord blood hematopoietic stem cells. In addition there are several ways for improving of homing of HSCs such as co- infusion of CB hematopoietic stem cells and mesenchymal stem cells, administration of parathyroid hormone (PTH), intra- bone transplantation and targeting the CXCR4/SDF1 system. These strategies are expected to increase the availability of transplantation to adults, for whom the chance to find a cord blood suitable for a single unit transplant is small. Recent advances in elucidation of the molecular mechanisms responsible for the proliferation and self-renewal of hematopoietic stem cells may bring further improvement of the outcomes of cord blood transplantation. This review summarizes the recent progress in the field of cord blood derived hematopoietic stem cells. It presents the strategies applied and points out directions for the future.

Original languageEnglish
Pages (from-to)425-433
Number of pages9
JournalStem Cell Reviews and Reports
Issue number2
StatePublished - Jun 2011


  • Cord blood
  • Expansion
  • Stem cells
  • Transplantation


Dive into the research topics of 'Cord Blood Stem Cells for Hematopoietic Transplantation'. Together they form a unique fingerprint.

Cite this